John Libbey Eurotext

European Journal of Dermatology


Latent tuberculosis infection: diagnostic update before introduction of biological drugs Volume 26, numéro 3, May-June 2016

Dermatology Unit,
Complejo Hospitalario Universitario,
Granada, Spain

Screening for latent tuberculosis infection (LTI) in patients who are going to undergo treatment with biological drugs (TNF blockers and anti IL12/23) to manage moderate-to-severe psoriasis has become a significant issue in countries such as Spain, with one of the highest tuberculosis incident rates of Western Europe (13 new cases per 100,000 persons/year, according to the World Health Organisation) [1]. The interferon-γ release assay (IGRA) has recently been introduced as a relevant diagnostic method [...]